1. Home
  2. NTRA vs FITB Comparison

NTRA vs FITB Comparison

Compare NTRA & FITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$231.21

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

FITB

Fifth Third Bancorp

HOLD

Current Price

$49.98

Market Cap

31.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
FITB
Founded
2003
1858
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
31.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
FITB
Price
$231.21
$49.98
Analyst Decision
Strong Buy
Buy
Analyst Count
15
17
Target Price
$249.53
$53.29
AVG Volume (30 Days)
1.1M
9.6M
Earning Date
02-26-2026
01-20-2026
Dividend Yield
N/A
3.21%
EPS Growth
N/A
12.42
EPS
N/A
3.53
Revenue
$2,116,676,000.00
$8,355,000,000.00
Revenue This Year
$33.77
$46.95
Revenue Next Year
$16.92
$7.42
P/E Ratio
N/A
$14.10
Revenue Growth
38.17
5.09
52 Week Low
$125.38
$32.25
52 Week High
$256.36
$53.33

Technical Indicators

Market Signals
Indicator
NTRA
FITB
Relative Strength Index (RSI) 44.72 55.29
Support Level $229.14 $49.08
Resistance Level $250.00 $51.16
Average True Range (ATR) 8.27 1.31
MACD -1.38 -0.15
Stochastic Oscillator 21.29 39.69

Price Performance

Historical Comparison
NTRA
FITB

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FITB Fifth Third Bancorp

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

Share on Social Networks: